AbInitio Bio

The Intelligence layer for Drug Manufacturing

Y CombinatorSpring 2026ActiveHealthcareDrug Discovery and DeliveryAI-powered Drug DiscoveryBiotechManufacturing

What they do

Problem

Drug manufacturing lacks an intelligence layer to monitor, optimize, and ensure reliable production processes and quality.

Solution

An intelligence software layer for drug manufacturing that analyzes production data to improve process control and decision-making.

Who it's for

Pharmaceutical and biotech drug manufacturing teams and operations leaders.

Founders

Daniel Mukasa

Founder & CEO

Founder & CEO at AbInitio Bio (YC P26). Postdoctoral Fellow at MIT focused on AI and drug discovery. Previously AI/ML intern at Merck working on antibody therapeutic design. PhD in Applied Physics and Materials Science from Caltech.

LinkedIn · X

Nisha Gopal

Founder

Founder CSO at Abinitio Bio (YC P26). Biochemist with 14 years of experience, Stanford PhD, former research scientist at the The Broad Institute of Harvard and MIT